A Study of RAY1225 in Participants With Impaired Kidney Function

NCT06613763 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Impairment

Interventions

DRUG: RAY1225

Sponsor

Guangdong Raynovent Biotech Co., Ltd